Human immunodeficiency virus type 1 infection in a community of southern Mozambique
Mencarini, P.; De Luca, A.; Ghirga, P.; Vichi, F.; Antinori, A.; Maiuro, G.; Noormahomed, I.; Tamburrini, E.
Tropical and Geographical Medicine 43(1-2): 39-41
1991
ISSN/ISBN: 0041-3232 PMID: 1750127 Document Number: 378584
We report the results of a study held between 1986 and 1988 on a population constituted by 493 subjects (425 of Mozambican nationality) all living in the camp organized for the building of the dam in Corumana (Sabiè district, Maputo). We found five subjects, all of them from Mozambique, seropositive for HIV-1 antibodies (ELISA and WB) with a prevalence of 1.2%. Four of the positive samples came from female subjects (1.7% of 239 females tested); one positive sample came from a male subject (0.5% of 186 tested).
Document emailed within 1 workday
Related Documents
Maueia, C.; Costa, D.; Meggi, B.; Ismael, N.; Walle, C.; Curvo, R.; Abreu, C.; Bhatt, N.; Tanuri, A.; Jani, I.V.; Ferreira, O.C. 2011: Frequency of human immunodeficiency virus type-2 in hiv infected patients in Maputo City, Mozambique Virology Journal 8: 408Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Parande, M.V.; Mantur, B.G.; Parande, A.M.; Shinde, R.S.; Roy, S.; Jnaneshwar, K.B.; Chandrashekhar, M.R. 2013: Seroprevalence of human immunodeficiency virus and hepatitis B virus co-infection in Belgaum, southern India Indian Journal of Medical Research 138(3): 364-365
Nagot, N.; Ouedraogo, A.; Konate, I.; Weiss, H.A.; Foulongne, V.; Defer, M.C.; Sanon, A.; Becquart, P.; Segondy, M.; Sawadogo, A.; Van de Perre, P.; Mayaud, P.; Bahembera, E.; Berthe, A.; Coulibaly, M.; Defer, M.-C.; Diallo, R.; Djagbare, D.; Konate, I.; Ky-Dama, F.; M'Boutiki, G.T.; Meda, N.; Millogo, I.; Ouedraogo, A.; Ouedraogo, D.; Rouet, F.ço.; Sanon, A.; Sawadogo, H.; Vallo, R.; Andonaba, J.-B.; Sawadogo, A.; Mayaud, P.; Weiss, H.A.; Nagot, N.; Becquart, P.; Foulongne, V.; Segondy, M.; Van de Perre, P. 2008: Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels Journal of Infectious Diseases 198(2): 241-249
Del Olmo, J.A.; Añón, C.; Llovet, F.; Serra, M.A.; Wassel, A.; Rodrigo, J.M. 1995: Comparative study of the prevalence of hepatitis B virus infection and human immunodeficiency virus type 1 infection in the prison population between 1985 and 1992 Gastroenterologia y Hepatologia 18(8): 405-409
Machado, A.A.; Hirsch, I.; Figueiredo, J.F.; Martinez, R.; de Freitas-Silva, G.; Chermann, J.C.; Covas, D.T. 1996: Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1) Revista da Sociedade Brasileira de Medicina Tropical 29(6): 615-617
1991: Human immunodeficiency virus type 1 infection of human placenta: potential route for fetal infection Disease Markers 9(6): 348
Devare, S.G.; Desai, S.M.; Rupprecht, K.R.; Allen, R.G.; Dawson, G.J.; Hunt, J.C.; Casey, J.M. 1988: Genes of human immunodeficiency virus, type i (HIV-I), their expression in Escherichia coli, and their utility in diagnosis of virus infection Indian Journal of Biochemistry and Biophysics 25(6): 504-509
Selimova, L.M.; Kalnina, L.B.; Serebrovskaya, L.V.; Ivanova, L.A.; Gulyaeva, A.N.; Nosik, D.N. 2016: Cytokines during the Human Immunodeficiency Virus Infection type 1(Hiv-1) Voprosy Virusologii 61(1): 39-41
Dusheiko, G.M.; Brink, B.A.; Conradie, J.D.; Marimuthu, T.; Sher, R. 1989: Regional prevalence of hepatitis B, delta, and human immunodeficiency virus infection in southern Africa: a large population survey American Journal of Epidemiology 129(1): 138-145
Mukolo, A.; Torres, I.; Bechtel, R.M.; Sidat, M.; Vergara, A.E. 2013: Consensus on context-specific strategies for reducing the stigma of human immunodeficiency virus/acquired immunodeficiency syndrome in Zambézia Province, Mozambique Sahara J: Journal of Social Aspects of Hiv/Aids Research Alliance 10(3-4): 119-130
Balzarini, J.; Velazquez, S.; San-Felix, A.; Karlsson, A.; Perez-Perez, M.J.; Camarasa, M.J.; De Clercq, E. 1993: Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues Molecular Pharmacology 43(1): 109-114
Yusim, K.; Peeters, M.; Pybus, O.G.; Bhattacharya, T.; Delaporte, E.; Mulanga, C.; Muldoon, M.; Theiler, J.; Korber, B. 2001: Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 356(1410): 855-866
Horsburgh, C.R.; Holmberg, S.D. 1988: The global distribution of human immunodeficiency virus type 2 (HIV-2) infection Transfusion 28(2): 192-195
Emery, S.; Cooper, D.A. 1995: Antiretroviral therapy of human immunodeficiency virus type-1 (HIV-1) infection Australian and New Zealand Journal of Medicine 25(4): 344-349
Mancino, G.; Placido, R.; Bach, S.; Mariani, F.; Montesano, C.; Ercoli, L.; Zembala, M.; Colizzi, V. 1997: Infection of human monocytes with Mycobacterium tuberculosis enhances human immunodeficiency virus type 1 replication and transmission to T cells Journal of Infectious Diseases 175(6): 1531-1535
Dunkle, L.M. 1995: Long-term survivors of human immunodeficiency virus type 1 infection New England Journal of Medicine 332(24): 1647; Author Reply 1647-1648
Hollak, C.E.; Kersten, M.J.; van der Lelie, J.; Lange, J.M. 1990: Thrombocytopenic purpura as first manifestation of human immunodeficiency virus type I (HIV-1) infection Netherlands Journal of Medicine 37(1-2): 63-68
Vázquez-Rosales, J.é G.; Solórzano-Santos, F.; Alvarez-Muñoz, M.T.; Sanchez-Huerta, G.; Miranda-Novales, M.G. 2004: Human immunodeficiency virus type 1 (HIV-1) infection in pediatric patients from Mexico Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 56(2): 153-168
Anonymous 1988: 1988 agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus Morbidity and Mortality Weekly Report 37(S-4): 22